Participants 46 149 4
adaptive functioning in children with pervasive developmental disorders and serious behavioral problems
Participants 162 216 4
Children with Pervasive Developmental Disorders (PDDs)
Participants 439 783 7
METHOD This 24-week, three-site, controlled clinical trial randomized 124 children (4 through 13 years of age) with PDDs and serious behavioral problems to medication alone (MED; n = 49; risperidone 0.5 to 3.5 mg/day; if ineffective, switch to aripiprazole was permitted) or a combination of medication plus parent training (PT) (COMB; n = 75).
Participants 784 851 4
Parents of children in COMB received an average of 11.4 PT sessions
Participants 2141 2189 3
Children With Pervasive Developmental Disorders;
